Celldex Therapeutics, Inc (CLDX) Financials
Key financial figures for Celldex Therapeutics, Inc (Q2 2026).
- Revenue
- $22K
- Net Income
- -$74M
- EPS
- $-0.94
- Total Assets
- $782M
- Operating Cash Flow
- -$57M
Full income statement, balance sheet, and cash flow for Celldex Therapeutics, Inc on SentiSense.